Provided is a method for making (±)-1-Cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolenecarboxylic acid, commonly known as gatifloxacin, in high purity, in a suspension in a dipolar aprotic solvent.
申请公布号
PL375437(A1)
申请公布日期
2005.11.28
申请号
PL20030375437
申请日期
2003.08.14
申请人
TEVA PHARMACEUTICAL INDUSTRIES LTD.
发明人
NIDDAM-HILDESHEIM VALERIE;DOLITZKY BEN-ZION;PILARSKI GIDEON;STERIMBAUM GRETA
